fbpx
News
May 4, 2017

In the News Today – May 4, 2017

J&J Gets a “Victory” With Xarelto Verdict: Johnson & Johnson scored a critical victory yesterday after a jury rendered a defense verdict in the first bellwether trial over the blood thinner Xarelto. The drug has been subject to “rampant advertising by plaintiffs’ attorneys in cases involving pharmaceuticals and medical devices.” This advertising “invites meritless cases” and “dire warnings in attorneys ads put patients at risk by convincing them to stop taking their medications,” notes the article. (National Law Journal)

FTC To Focus on “Real Harm” Says Chair: Acting FTC Chair Maureen Ohlhausen vowed to focus “on cases in which business activity has led to actual and substantial harm.” Ohlhausen went on to say that under the previous administration, there was sometimes “too great a willingness” to take regulatory actions based on perceived harms to the consumers that were “not grounded in either testable empirical facts or sound economic theory.” (Law360

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings